NCT00423995View on ClinicalTrials.gov

Effect of Loratadine/Montelukast Combination on Congestion in SAR Patients Exposed to Pollen in an EEU (Study P04822)

PHASE3CompletedINTERVENTIONAL

Enrollment

379

Participants

Timeline

Start Date

November 1, 2006

Primary Completion Date

March 1, 2007

Study Completion Date

March 10, 2007

Conditions

Seasonal Allergic Rhinitis

Interventions

DRUG

Loratadine/montelukast combination

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00423995 - Effect of Loratadine/Montelukast Combination on Congestion in SAR Patients Exposed to Pollen in an EEU (Study P04822) | Biotech Hunter | Biotech Hunter